T. Rowe Price Associates »

Indivior Pharmaceuticals shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Indivior Pharmaceuticals (INDV) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Indivior Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Indivior Pharmaceuticals held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Indivior Pharmaceuticals by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.2M 139k 30.49

More positions owned by T. Rowe Price Associates

Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Microsoft Corp Comm Stk (MSFT)
Broadcom Comm Stk (AVGO)
Amazon Comm Stk (AMZN)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Netflix Comm Stk (NFLX)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Jpmorgan Chase & Co Comm Stk (JPM)
Ge Aerospace Comm Stk (GE)

View all positions for T. Rowe Price Associates

Top funds holding Indivior Pharmaceuticals

BlackRock
Vanguard Portfolio Management
Oaktree Capital Management
Vanguard Capital Management
State Street Corporation
Two Seas Capital
Millennium Management
Hanna Zanoni
Madison Avenue Partners
Citadel Advisors
Morgan Stanley
Deerfield Management Company
Geode Capital Management
Mangrove Partners
Goldman Sachs Group

View all funds holding Indivior Pharmaceuticals